Navega a Otras Criptomonedas

NVSNovartis AG

Enlaces Rápidos

Calculadora de Posición

Tamaño de Posición (USD)Apalancamiento

Margen Requerido

$10.00

P&L si NVS se mueve

+1%+$10.00

+5%+$50.00

+10%+$100.00

Comienza a Operar con Apalancamiento de {leverage}x

Novartis AG

NVS

$151.00

+0.00% (24h)

AccionesNivel CApalancamiento 1000x

Puntos Clave

Última actualización:: 2026-07-06

•Novartis acordó adquirir la empresa británica Myricx Bio por hasta $1.5 mil millones (pago inicial + hitos), con cierre previsto para el segundo semestre de 2026 — una transacción vinculante confirmada.
•El acuerdo se enfoca en la tecnología NMTi-ADC, reforzando los conjugados anticuerpo-fármaco como la frontera de innovación más disputada de la industria farmacéutica.
•El adquirente (NVS) puede enfrentar presión de venta a corto plazo mientras los inversores evalúan el riesgo de hitos; acuerdos similares previos han producido caídas iniciales modestas.
•Los competidores biotecnológicos centrados en ADC se benefician de una mayor probabilidad de adquisición y una presión al alza sobre los múltiplos de valoración.
•La salida de la biotecnología británica valida el ecosistema de oncología de precisión del Reino Unido y proporciona una señal positiva leve para las empresas de ciencias de la vida cotizadas en Londres y los índices europeos de atención médica.

Precio y Estructura del Mercado

Cargando gráfico...

Estado del Régimen de Trading

Apalancamiento

1000x

(Máximo en CoinUnited.io)

Volatilidad

N/A

Glosario

Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.

Stock CFD	A contract for difference on a share price — price exposure only, not ownership of the underlying shares.
Extended hours	Pre-market and after-hours trading outside the exchange’s regular session.
Basis risk	The risk that the CFD reference price and the exchange execution price do not move in step.
P/E	Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge.
Gross margin	Gross profit ÷ revenue; reflects product-level profitability.
EPS	Earnings per share = net income ÷ diluted shares outstanding.

Últimos Pulsos

2026-07-06AccionesAlcista

NVS

Novartis paga hasta $1.5 mil millones por la biotecnológica británica Myricx Bio, profundizando la carrera armamentista de los ADC

Según lo informado por GlobeNewswire y confirmado en la prensa financiera, Novartis AG ha acordado adquirir la empresa británica Myricx Bio por hasta $1.5 mil millones en un acuerdo vinculante que se

Ver todos los pulsos de NVS

Get Started with Novartis AG

Start trading Novartis AG on CoinUnited.io with industry-leading leverage and zero fees.

Trade with Leverage

Trade NVS CFDs with up to 1000x leverage on CoinUnited.io.

Up to 1000x leverage
Zero trading fees
Advanced risk management tools

Trade NVS Now

Explore Stocks

Browse the full stocks market on CoinUnited.io with 125+ instruments.

125+ stocks instruments
Real-time market data
Professional charting tools

Browse Stocks

Learn Stocks Trading

Read our in-depth research and analysis on stocks markets.

Expert market analysis
Technical analysis basics
Daily market insights

Read Our Research

How to Trade Novartis AG: Step-by-Step Guide

Learn how to trade Novartis AG (NVS) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.

Create Your CoinUnited.io Account

✓Quick and free registration
✓Email and password setup
✓Two-factor authentication for security

Verify Your Identity

Complete the KYC verification process to unlock full trading features and higher limits.

✓Upload government-issued ID
✓Proof of address document
✓Usually verified within minutes

Deposit Funds

Fund your account using one of the supported deposit methods.

Deposit Methods

•Cryptocurrency deposits (BTC, ETH, USDT)
•Bank transfer available
•No minimum deposit requirement

Find NVS in the Stocks Section

Navigate to the stocks market section and search for NVS. You can trade Novartis AG as a CFD with up to 1000x leverage.

✓Search for "NVS" in the trading platform
✓Select CFD trading mode
✓Review the current price and market data

Place Your Trade

Choose your position direction (long or short), set your leverage, and enter your position size to trade Novartis AG.

✓Long (buy) if you expect NVS to rise
✓Short (sell) if you expect NVS to fall
✓Set stop-loss and take-profit levels

Monitor & Manage Risk

Keep track of your open positions and manage risk with stop-loss orders and position sizing.

✓Monitor P&L in real-time
✓Adjust stop-loss as needed
✓Never risk more than you can afford to lose

Order Types

Market Order

Execute immediately at the current market price. Best for quick entries.

Limit Order

Set a specific price to enter. The order fills only when the market reaches your price.

Stop-Loss Order

Automatically close your position at a specified price to limit potential losses.

Important Tips

• Start with a small position to understand how leverage works
• Always set a stop-loss to protect your capital
• Higher leverage amplifies both gains and losses
• Never invest more than you can afford to lose

¿Listo para operar Novartis AG?

Hasta 1000x de apalancamiento

Comienza a operar NVS

símbolo

NVS

Mercados

Acciones

Sector

General

Código de producto CU

NVS

Etiquetas

Coinbase UK License Multiasset ExpansionCoinbase UK Derivatives Exchange LaunchAI Monetization Revenue Race

Similar Stocks Assets

Explore other stocks instruments in the same sector as Novartis AG. Compare performance and find trading opportunities.

USA Rare Earth, Inc.

$19.24

▲12.4%

Direxion Daily TSLA Bull 2X Shares

$9.79

▲10.1%

MP Materials Corp.

$60.02

▲8.9%

Tempus AI, Inc

$72.73

▲8.8%

ProShares UltraShort Silver

$24.60

▲8.5%

View all General →

Sobre el Autor

CoinUnited.io Research Team

This Novartis AG page is compiled by CoinUnited.io's research team: analysts covering listed equities and global markets, working from primary filings and named third-party data rather than opinion.

Nuestra Metodología de Investigación

Every figure is traced to a primary or named third-party source and dated: financial statements from the company’s SEC filings, institutional ownership from Form 13F, analyst targets from aggregated third-party coverage, and market data from the CoinUnited reference price. The Source Map on this page lists each one with its source and the date we last checked it.

Disclaimer: content is for informational and educational purposes only and is not personalized financial advice. A stock CFD carries significant risk and provides price exposure only, not equity ownership. Always conduct your own research and consult a qualified financial advisor.

Avisos legales y referencias

Aviso Importante sobre Riesgos

A CoinUnited stock CFD gives price exposure to Novartis AG only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.

Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.

Los usuarios deben realizar su propia investigación y consultar con profesionales financieros cualificados antes de tomar cualquier decisión de inversión. Los creadores y operadores de esta plataforma no asumen ninguna responsabilidad por pérdidas financieras u otros daños que puedan derivarse de la confianza depositada en la información proporcionada.

Leveraged trading is extremely risky and you may lose your entire deposit.

Resumen de la metodología

Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.

Financial statements: the company’s own SEC filings (10-K / 10-Q), read from XBRL
Market data: the CoinUnited reference price and daily closes
Institutional ownership: SEC Form 13F quarterly filings
Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited’s view
Peer multiples: third-party trailing-twelve-month ratios

CoinUnited does not publish a price forecast or target for Novartis AG.

Última revisión de la metodología:

¿Listo para comenzar a operar con Novartis AG?

Únase a miles de traders y comience su viaje de trading de Novartis AG hoy. Obtenga acceso a herramientas de trading avanzadas y tarifas competitivas.

Operar NVS/USDT Regístrate Ahora